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Objectives This study sought to analyze multidetector computed tomography (MDCT) 3-dimensional aortic annular dimensions
for the prediction of paravalvular aortic regurgitation (PAR) following transcatheter aortic valve replacement (TAVR).
Background Moderate or severe PAR after TAVR is associated with increased morbidity and mortality.
Methods A total of 109 consecutive patients underwent MDCT pre-TAVR with a balloon expandable aortic valve. Differ-
ences between transcatheter heart valve (THV) size and MDCT measures of annular size (mean diameter, area,
and circumference) were analyzed concerning prediction of PAR. Patients with THV malposition (n  7) were
excluded. In 50 patients, MDCT was repeated after TAVR to assess THV eccentricity (1 – short diameter/long
diameter) and expansion (MDCT measured THV area/nominal THV area).
Results Moderate or severe PAR (13 of 102) was associated with THV undersizing (THV diameter – mean diameter 
–0.7  1.4 mm vs. 0.9  1.8 mm for trivial to mild PAR, p  0.01). The difference between THV size and MDCT
annular size was predictive of PAR (mean diameter: area under the curve [AUC]: 0.81, 95% confidence interval
[CI]: 0.68 to 0.88; area: AUC: 0.80, 95% CI: 0.65 to 0.90; circumference: AUC: 0.76, 95% CI: 0.59 to 0.91). An-
nular eccentricity was not associated with PAR (AUC: 0.58, 95% CI: 0.46 to 0.75). We found that 35.3% (36 of
102) and 45.1% (46 of 102) of THVs were undersized relative to the MDCT mean diameter and area, respec-
tively. THV oversizing relative to the annular area was not associated with THV eccentricity or underexpansion
(oversized vs. undersized THVs; expansion: 102.7  5.3% vs. 106.1  5.6%, p  0.03; eccentricity: median:
1.7% [interquartile range: 1.4% to 3.0%] vs. 1.7% [interquartile range: 1.1% to 2.7%], p  0.28).
Conclusions MDCT-derived 3-dimensional aortic annular measurements are predictive of moderate or severe PAR following
TAVR. Oversizing of THVs may reduce the risk of moderate or severe PAR. (J Am Coll Cardiol 2012;59:
1287–94) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.015Paravalvular aortic regurgitation (PAR) remains an impor-
tant limitation of transcatheter aortic valve replacement
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morbidity and mortality (4). The
2 main causes of PAR are under-
sizing of the transcatheter heart
valve (THV) relative to the aortic
annulus and incorrect device po-
sitioning (5–7). Treatment of severe
PAR due to THV undersizing is
challenging and unsatisfactory.
Sizing THVs is traditionally
performed using echocardiographic
assessment of the aortic annulus
relying on a single 2-dimensional
measurement. The aortic annulus,
however, is oval in configuration
(8–10) and multidetector com-
puted tomography (MDCT) of-
fers a 3-dimensional alternative for
image reconstruction of the aortic annulus in a proven repro-
ducible fashion (9). However, questions remain as to whether
MDCT annular measurements can predict significant PAR
after TAVR and how MDCT should be integrated into
THV-sizing protocols. This study aims to address this and to
review the impact of annulus eccentricity and THV oversizing
on valve expansion and circularity.
Methods
Patient selection. A total of 109 consecutive patients who
underwent a screening MDCT before TAVR with a bal-
loon expandable THV (Sapien XT or Sapien, Edwards
Lifesciences, Irvine, California) were enrolled from 2 cen-
ters (90 from St. Paul’s Hospital, Vancouver, Canada, and
19 from Aarhus University Hospital Skejby, Aarhus, Den-
mark) between January 2010 and June 2011. All patients
gave informed written consent. Subjects with renal impair-
ment (glomerular filtration rate 30 ml/min) did not
Abbreviations
and Acronyms
CI  confidence interval
IQR  interquartile range
kVp  peak kilovolts
MDCT  multidetector
computed tomography
OR  odds ratio
PAR  paravalvular aortic
regurgitation
TAVR  transcatheter
aortic valve replacement
TEE  transesophageal
echocardiography
THV  transcatheter heart
valve(s)
Figure 1 Grading of THV Position
(A) Correct, (B) too high, and (C) too low. THV  transcatheter heart valve(s).undergo MDCT. The TAVR procedure has been previ-
ously described (11,12).
THV selection. During the course of this study, the
Sapien valve was available in 23- and 26-mm nominal
diameters and the Sapien XT in 20-, 23-, 26-, and 29-mm
nominal diameters. In our institutions, THV sizing was
multifactorial. In addition to transesophageal echocardiog-
raphy (TEE) measures of the annulus, it was dependent on
patient size, sex, left main height, and root calcification. For
example, in our cohort, there are patients for whom the
intraprocedural TEE supported the implantation of a dif-
ferent THV size than the operator elected to choose.
MDCT was used for assessment of the iliofemoral system,
coronary ostia height, and prediction of the fluoroscopic
annular plane (13).
THV position. THV position was retrospectively reviewed
independently by 2 experienced interventional cardiologists
(J.W. and A.W.), who were blinded to the grade of aortic
regurgitation, prosthesis size, and MDCT annular measure-
ments. THV positioning was graded as correct, too high, or
too low based on pre- and post-implant aortic root angiog-
raphy. A prosthesis was considered high when the inflow of
the prosthesis (and sealing cuff) was above the basal inser-
tion of the native leaflets and low when the outflow portion
of the sealing cuff was below the most basal insertion of the
native leaflets (Fig. 1). Subjects in whom the prosthesis was
implanted too high or low (n  7) were not included in the
analysis as malposition is a distinct and separate cause of
PAR (6,7).
Assessment of aortic regurgitation by echocardiography.
Pre-discharge transthoracic echocardiography was per-
formed in all patients and interpreted by 3 experienced level
III echocardiographers, who were unaware of the pre-
operative annulus dimensions and size of prosthesis. Aortic
regurgitation was graded mild, moderate, or severe accord-
ing to the Valve Academic Research Consortium criteria
(14). Trivial jets were defined as those that were extremely
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and judged to be hemodynamically insignificant. For the
purposes of this analysis, trivial jets were grouped with no
aortic regurgitation. Cases with discrepancies in grading
among observers were resolved by consensus.
MDCT image acquisition. MDCT examinations were
performed on either a 64-slice Discovery HD 750 High
Definition scanner (GE Healthcare, Milwaukee, Wiscon-
sin) or a Siemens Somatom Definition Flash Dual-Source
scanner (Siemens Healthcare, Erlangen, Germany). Pa-
tients were injected with 80 to 120 ml of iodixanol 320 (GE
Healthcare, Princeton, New Jersey) at 5 cc/s followed by 30
cc of normal saline. MDCT examinations were acquired in
the craniocaudal direction with retrospective gating. Heart
rate reduction with beta-blockade was not performed.
MDCT scanner detector collimation width was 0.625 mm,
detector coverage 40 mm, reconstructed slice thickness 1.25
mm, slice increment 1.25 mm, gantry rotation time 0.35 s,
and the scan pitch 0.16 to 0.20 (adjusted per heart rate).
Depending on patient size, maximum tube current ranged
between 450 and 700 mA with a fixed tube voltage of 100
kVp for patients with a body mass index 30 kg/m2 and
120 kVp used in larger patients. Electrocardiogram-gated
dose modulation was used with tube current reduced to 60%
of maximum tube current in systole.
MDCT image analysis. All MDCT examinations were
evaluated by a single level III cardiac CT reader (J.L.). The
datasets were reconstructed to achieve a double oblique
transverse reconstruction at the level of the virtual basal ring
(aortic annulus) in a fashion described previously (15–17).
Image data were analyzed offline on a 3-dimensional work-
station (AW 4.4, GE Healthcare, Waukesha, Wisconsin).
To assess generalizability of MDCT annular measurements
for the prediction of PAR, 70 cases were randomly selected
and reviewed by 2 external readers (T.M.L. and S.A.).
Cases were read offline on different workstations OSIRIX
Figure 2 Three-Dimensional MDCT Aortic Annular Measuremen
(A) Short and long diameters provide a mean annulus diameter and annular eccen
MDCT  multidetector computed tomography.MD (version 3.9.4, Pixmeo, Geneva, Switzerland) and
Leonardo (Siemens Medical Systems, Erlangen, Germany).
Measuring the difference between THV size and annular
size for the prediction of PAR. Annular size was mea-
sured by TEE and MDCT. The TEE annular diameter was
measured mid systole from the point of basal leaflet inser-
tion as previously described (18). MDCT annular measure-
ments include a mean diameter, area, and circumference
(Fig. 2). The MDCT mean annular diameter was taken by
averaging the short and long diameters. Aortic annular
eccentricity was calculated as: 1 – short diameter/long
diameter.
The difference between the nominal THV size and
annular dimensions was measured by the following methods
and then assessed for prediction of PAR:
1. THV diameter – TEE annular diameter
2. THV diameter – MDCT mean annular diameter
3. THV area/MDCT annular area
4. THV circumference/MDCT annular circumference
The external area of a fully expanded (i.e., nominal) THV
is 3.14 cm2 for the 20-mm THV, 4.15 cm2 for the 23-mm
HV, 5.31 cm2 for a 26-mm THV, and 6.61 cm2 for the
29-mm THV. Nominal circumference is 62.8 cm for the
20-mm THV, 72.3 cm for the 23-mm THV, 81.7 mm for
the 26-mm THV, and 91.1 mm for the 29-mm THV.
Oversizing or undersizing a THV. A THV was deemed
oversized when the THV diameter was greater than the
MDCT mean annular diameter or when the THV nominal
area was greater than the MDCT annular area. The
percentage of oversizing (positive percentage) or undersiz-
ing (negative percentage) was calculated using the formula:
(THV area/annular area – 1)  100.
Post-implant geometry of the balloon expandable valves.
In 50 patients, post-TAVR THV geometry was assessed
before hospital discharge by MDCT. The THV was as-
sessed at the level of the floor of the Sinus of Valsalva to
. (B) Annular area. (C) Annular circumference.ts
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cross section for a short and long external stent diameter.
The external margins of the stent were traced to generate
the post-TAVR MDCT THV area. THVs were assessed
for eccentricity (1 – short diameter/long diameter) and
expansion (MDCT measured THV external area/nominal
THV area). A THV was circular when eccentricity was
10% (19,20) and 100% expansion represented a fully
expanded THV. The effect of oversizing a THV relative to
the MDCT annular area on THV eccentricity and expan-
sion was assessed.
Statistical methods. Continuous variables are described as
mean  SD or median (interquartile range [IQR]). Cate-
gorical variables are described by frequencies and percent-
ages. Continuous parametric variables were compared using
unpaired and paired Student t test as appropriate. Contin-
ous nonparametric variables were compared using the
ann-Whitney U test. Categorical variables were com-
ared using Fisher exact test. Intraclass correlation coeffi-
ient was defined as the ratio of between-subject variance to
he total. One-way analysis of variance was used to compare
he difference in means from 3 groups of PAR grade. Area
nder the receiver-operating characteristic curves were per-
ormed to test discriminatory power of clinical characteris-
ics, MDCT, and TEE measures for prediction of moderate
r severe PAR. Analyses were performed using SAS (ver-
ion 9.1.3, SAS Institute, Cary, North Carolina).
esults
linical characteristics are described in Table 1 and proce-
ure characteristics in Table 2. The mean MDCT mean
nnular diameter was greater than the mean TEE annular
iameter (23.9  2.4 mm vs. 22.5  1.9 mm, p  0.001).
ther mean MDCT systolic annular measurements in-
lude: short diameter: 21.1 2.4 cm, long diameter: 26.8
.0 cm, eccentricity: 21.2  7.1%, area: 4.7  0.9 cm2, and
circumference: 79.6  9.3 cm2. The THV size was on
verage 2.2  1.2 mm greater than the TEE diameter,
Baseline Patient Characteristics (N  102)Table 1 Baseline Patient Characteristics (N  102)
Age, yrs 81.3 8.3
Female 51 (50.0%)
Diabetes 25 (24.5%)
GFR, ml/min 56.5 21.6
STS PROM 6.6 (4.0–8.5)
Prior CABG 29 (28.4%)
LVEF, % 54.8 12.8
Height, cm 166.7 16.1
Weight, kg 76.7 20.8
Mean aortic valve area, cm2 0.70 0.17
Mean transaortic gradient, mm Hg 43.5 17.0
Moderate/severe MR 22 (22.5%)
Values are mean  SD, n (%), or median (25th to 75th percentile).
CABG  coronary artery bypass graft surgery; GFR  glomerular filtration rate; MR  mitral
regurgitation; STS PROM  Society of Thoracic Surgeons predicted risk of mortality..6  1.9 mm greater than the MDCT mean annulardiameter, 4.0 16.6% greater than the MDCT annular area, and
1.0  8.6% less than the MDCT annular circumference.
Interobserver reliability of MDCT annular measurements as
measured by the intraclass correlation coefficient are: mean
annular diameter: 0.84 (IQR: 0.78 to 0.90), area: 0.81
(IQR: 0.60 to 0.90), long diameter: 0.78 (IQR: 0.68 to
0.85), circumference: 0.77 (IQR: 0.65 to 0.85), and short
diameter: 0.70 (IQR: 0.49 to 0.82).
Prediction of PAR. Table 3 and Figure 3 show the
receiver-operating characteristic curve analysis for MDCT,
TEE, and demographic variables. Annular eccentricity, age,
and sex were not predictive of PAR. The difference between
THV diameter and TEE diameter provided moderate
prediction of PAR (area under the curve: 0.70, 95% confi-
dence interval [CI]: 0.51 to 0.88), whereas the relationship
between THV size and 3-dimensional MDCT annular size
(using diameter, area, and circumference measures) had
moderate to good predictive value. These findings were
consistent across all 3 MDCT readers.
The impact of THV undersizing on PAR. Undersizing of
a THV relative to the MDCT mean annular diameter
(THV diameter  mean annular diameter) was present in
35.3% (36 of 102) of patients and in 45.1% (46 of 102) of
patients by MDCT area (THV area  MDCT annular
area). Moderate or severe PAR was associated with under-
Procedural Characteristics (N  102)Table 2 Procedural Characteristics (N  102)
Valve type
Sapien 10 (9.2%)
Sapien XT 92 (90.8%)
Valve diameter size, mm
20 2 (2.0%)
23 46 (45.1%)
26 50 (49.0%)
29 4 (3.9%)
Access route
Femoral 70 (68.6%)
Apical 32 (31.4%)
Mean aortic valve area after TAVR, cm2 1.49 0.27
Mean transaortic gradient after TAVR, mm Hg 11.0 4.2
Aortic regurgitation
Paravalvular
None/trivial 47 (46.1%)
Mild 42 (41.2%)
Moderate 12 (11.8%)
Severe 1 (1.0%)
Transvalvular
None/trivial 99 (97.0%)
Mild 2 (2.0%)
Moderate 0 (0%)
Severe 1 (1.0%)
Annular rupture 0 (0%)
Device embolization 0 (0%)
Procedural mortality 0 (0%)
30-day mortality 5 (4.9%)Values are n (%) or mean  SD.
TAVR  transcatheter aortic valve replacement.
0
a
T
o
M
5
o
r
a
e
3
h
h
5
l
a
e
u
a
m
aphy; N
r
1291JACC Vol. 59, No. 14, 2012 Willson et al.
April 3, 2012:1287–94 CT Predicts TAVR Paravalvular Regurgitationsizing of the THV relative to the mean annular diameter
and annular area by MDCT, whereas none or trivial PAR is
associated with oversizing of the THV (Table 4, Fig. 4).
Clinical, procedural, and echocardiographic characteristics
for undersized versus oversized THV by MDCT area are
displayed in Table 5.
We then dichotomized the difference between THV size
and annular area and THV size and mean annular diameter
at potentially clinically meaningful values. For patients with
a THV diameter – mean annulus diameter 1 mm (56 of
102, 54.9%), the incidence of moderate or severe PAR was
21.4% versus 2.2% (odds ratio [OR]: 9.4, 95% CI: 2.15 to
88.8, p  0.01) when the THV diameter – mean annular
diameter 1 mm (46 of 102, 46.1%). For patients with a
THV nominal area 10% greater than the annular area (68
Area Under the Receiver-Operator Curve for the Prediction of ModeTable 3 Area Under the Receiver-Operator Curve for the Predic
MDCT Reader 1 (N  102
AUC 95% C
THV diameter – mean diameter 0.81 0.68–0.8
THV area/annular area 0.80 0.65–0.9
THV circumference/annular circumference 0.76 0.59–0.9
THV diameter – TEE annulus diameter 0.70 0.51–0.8
Female 0.62 0.50–0.7
Age, yrs 0.59 0.50–0.7
Annular eccentricity 0.58 0.46–0.7
AUC  area under the curve; CI  confidence interval; MDCT  multidetector computed tomogr
eplacement; TEE  transesophageal echocardiography; THV  transcatheter heart valve(s).
Figure 3 Area Under the Receiver-Operating Characteristic
Curves for Prediction of PAR
MDCT mean diameter (0.81, 95% confidence interval [CI]: 0.68 to 0.88), MDCT
area (0.80, 95% CI: 0.65 to 0.90), and transesophageal echocardiography
(TEE) diameter (0.70, 95% CI: 0.51 to 0.88). PAR  paravalvular aortic regurgi-
tation; other abbreviations as in Figures 1 and 2.of 102, 66.7%), the incidence of moderate or severe PAR
was 19.1% versus 0% (OR: 18.4, 95% CI: 2.3 to 100, p 
.01) for THVs with a nominal area 10% above the
nnular area (34 of 102, 33.3%).
he impact of annular eccentricity and THV oversizing
n THV geometry. Fifty patients underwent post-TAVR
DCT (Fig. 5). THV circularity was present in 98% (49 of
0) and mean THV expansion of was 104.0  5.6%.
Eccentricity at the annular level was reduced following
TAVR (21.5  7.3% vs. 2.1  1.7%, p  0.001). Thirty-
ne (62%) patients received a THV that was oversized
elative to the MDCT annular area (THV area  MDCT
nnular area). THV oversizing by area did not affect THV
ccentricity (oversized vs. undersized: 1.7% [IQR: 1.4 to
.0] vs. 1.7% [IQR: 1.1 to 2.7], p 0.28). Oversized THVs
ad marginally less expansion than undersized THVs;
owever, on average, remained fully expanded (102.7 
.3% vs. 106.1  5.6%, p  0.03). The 2 patients with the
argest percentage of THV oversizing (THV area was 59.8%
nd 47.8% greater than the annular area) had the lowest THV
xpansion at 90.3% and 91.7%, respectively. Despite THV
nderexpansion, hemodynamics were satisfactory. (Case 1:
ortic valve area 1.3 cm2, mean gradient 9 mm Hg in a 23-mm
valve; Case 2: aortic valve area 1.8 cm2 and mean gradient 15
m Hg in a 26-mm valve).
or Severe PAR After TAVRf Moderate or Severe PAR After TAVR
MDCT Reader 2 (n  70) MDCT Reader 3 (n  70)
AUC 95% CI AUC 95% CI
0.85 0.72–0.96 0.84 0.63–0.97
0.79 0.58–0.94 0.86 0.70–0.97
0.76 0.54–0.96 0.86 0.73–0.97
NA NA
NA NA
NA NA
0.61 0.49–0.81 0.57 0.49–0.73
A  not applicable; PAR  paravalvular aortic regurgitation; TAVR  transcatheter aortic valve
The Relationship BetweenUndersizing a THV Relative to the MDCTA nular S ze and Incre si g Grade of PAR
Table 4
T e Relationship Between
Undersizing a THV Relative to the MDCT
Annular Size and Increasing Grade of PAR
Grade of PAR
THV Diameter – Mean
Annular Diameter
(mm)
Percentage Difference
Between the THV Area and
Annular Area*
None/trivial 1.5 1.8 14.2 18.3
Mild 0.4 1.8 4.3 14.2
Moderate/severe 0.7 1.4 7.0 9.5
p value 0.01 0.01
Values are mean  SD and measured in systole. *A positive percentage represents the amount
that the THV area is greater than the annular area. Conversely, a negative percentage represents
the amount that the THV area is less than the annular area. Calculated by (THV area/annularratetion o
)
I
8
0
1
8
7
2
5area – 1)  100.
Abbreviations as in Table 3.
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This study demonstrates that MDCT annular measure-
ments have good predictive value of moderate or severe
PAR following TAVR. Differences between nominal THV
size and MDCT mean annular diameter and area demon-
strated the strongest relationship. Importantly, these find-
ings were consistent across multiple MDCT readers from
Figure 4 Case Example of THV Undersizing Causing Significant
(A) A 23-mm Sapien XT (Edwards Lifesciences, Irvine, California) valve was select
is 25 mm (22  28 mm) and area 4.90 cm2. The THV is undersized by 2 mm rela
appears undersized on aortic root angiography. (D) Moderate PAR on echocardiog
Clinical, Procedural, and Echocardiographicharacteristics of Undersized (THV Nominal Area< MDCT Area) Versus Oversized THV (THV NominalArea > MDCT Ar a)
Table 5
Clinical, Procedural, and Echocardiographic
Characteristics of Undersized (THV Nominal Area
< MDCT Area) Versus Oversized THV (THV Nominal
Area > MDCT Area)
Undersized
(n  46)
Oversized
(n  56) p Value
Clinical characteristics
Age, yrs 80.1 9.2 82.2 7.5 0.22
Sex 0.05
Female 19 (41.3%) 32 (57.1%)
Male 27 (58.7%) 24 (42.9%)
STS PROM 6.9 3.7 6.4 3.3 0.47
GFR, ml/min 53.6 22.1 58.7 21.2 0.25
Height, cm 167.1 22.6 166.4 11.0 0.86
Weight, kg 80.7 24.2 74.3 18.3 0.20
Procedural characteristics
Access route 0.03
Femoral 28 (60.8%) 44 (78%)
Apical 18 (39.1%) 12 (21.4%)
Mean THV diameter size, mm 24.5 1.98 24.8 1.69 0.38
Echocardiographic characteristics
Mean aortic valve area, cm2 0.70 0.19 0.70 0.17 0.96
Mean transaortic gradient, mm Hg 43.3 17.0 43.6 17.2 0.92
Post-TAVR mean aortic valve
area, cm2
1.45 0.26 1.55 0.31 0.13
Post-TAVR mean aortic gradient,
mm Hg
11.5 4.7 10.8 4.0 0.48
PAR
None/trivial 13 (28.3%) 34 (60.7%) 0.01
Mild 24 (52.2%) 18 (32.1%) 0.02
Moderate or severe 9 (19.6%) 4 (7.1%) 0.04Values are mean  SD or n (%).
Abbreviations as in Tables 1 and 3.different institutions and countries using a variety of work-
stations, suggesting that these findings are generalizable.
Aortic annular measurements: which to use in clinical
practice? Accurate and reproducible measurements of the
aortic annulus are crucial for optimum sizing of THVs. It is
well established that the aortic annulus is a noncircular struc-
ture (8–10), and, in our cohort, the mean difference between
the short and long annular diameters was 5.7 mm (21%).
Two-dimensional TEE annular diameters are on average 1.4
mm less than the mean annular diameter on MDCT. We do
not intend to suggest that MDCT is superior to TEE but
rather that MDCT with 3-dimensional measures can provide
complementary and additive information in the assessment of
patients undergoing TAVR. However, we do believe that the
2-dimensional TEE annular diameter may underestimate the
“true” annular size. MDCT with its isotropic voxels and
multiplanar reformat capabilities offers the ability to routinely
reconstruct the annulus in its true plane with double oblique
transverse projections. With this reconstruction, there are
multiple annular measurements that can be taken including
mean diameter, area, and circumference. An area-derived
diameter, circumference-derived diameter, and annular eccen-
tricity index can also be calculated. This extensive information
has the potential to create confusion. The present data establish
that the 2 most reproducible and predictive MDCT annular
measurements of PAR are mean diameter and area.
Our data suggest that in order to minimize the risk of
significant PAR, the implanted THV size should be greater
than the 3-dimensional annular size by MDCT. THVs that
were oversized relative to the MDCT mean annular diam-
eter by at least 1 mm and annular area by at least 10% had
a significantly reduced risk of moderate or severe PAR.
However, THV oversizing may come at a cost, with a potential
greater risk of coronary occlusion or annular rupture, and future
studies are warranted to assess the safety and feasibility before
intentional oversizing should be performed.
When considering what THV size to implant, it is worth
considering the increase in THV area when going from the
ed on a TEE annular diameter of 22 mm. (B) The MDCT mean annular diameter
the mean diameter and by 15% relative to the annular area. (C) The THV
Abbreviations as in Figures 1, 2, and 3.PAR
ed bas
tive to
raphy.smaller to larger THV (Fig. 6). Upsizing from a 23-mm to
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exponential 28% increase in external valve area. In the
future, as sizing of THVs becomes more meticulous
through 3-dimensional measurements, it seems likely that a
greater range of THV sizes will become available.
Post-implant THV geometry and the impact of oversizing
and annular eccentricity on THV expansion and eccentricity.
Balloon expandable THVs have excellent rates of circularity
and complete expansion. Modest oversizing of a THV
relative to the annular area did not affect THV expansion,
whereas extreme oversizing (i.e., THV area 50% greater
than annular area) did result in underexpansion of the THV.
The clinical importance of this is unknown. The low
eccentricity of the THV despite annular eccentricity sug-
gests the aortic annulus is somewhat compliant and con-
formable to the THV. This may explain why annular
eccentricity was not predictive of PAR.
Figure 5 The Effect of Aortic Annular Eccentricity and THV Ove
Eccentricity as Demonstrated by Matched Pre- and Po
(A) At baseline, the aortic annulus is eccentric (29%) with a mean diameter of 20
23-mm THV, MDCT shows a circular implant (23.2 mm  23.5 mm, eccentricity 1
is fully expanded with an expansion ratio of 103.6% (THV area  4.30 cm2). TAVR
Figure 6 Area as a Measure of Balloon Expandable THV Size
Nominal external valve area can be used for sizing of balloon expandable THVs. A
the MDCT annular area. Nominal THV area increases by 28% from a 23- to 26-mmStudy limitations. Despite a large cohort, the prevalence of
significant PAR in this study was relatively low. Aortic
annular calcification was not measured by MDCT. Severe
calcification may have an impact on PAR severity, annular
measurement, and THV geometry. There were no cases of
aortic root rupture following TAVR, so risk of this through
oversizing of a THV could not be assessed. MDCT accu-
racy in assessing the annulus may be affected by motion
artifact, which may reduce accuracy of measurements. In
addition, when dose modulation is used, image quality may
be reduced. Nevertheless, in this study where patients were
not rate controlled before MDCT, and in whom dose
modulation was used, we observed high inter-reader corre-
lation. Finally, the current study did not assess the utility of
3-dimensional TEE measurements, which, in principle,
may provide similar measurements to 3-dimensional
MDCT.
g on THV Expansion and
VR MDCT in an Individual Patient
(17.0 mm  24.1 mm) and area of 3.45cm2. (B) Following implantation of a
C) Despite the THV being oversized relative to the annular area by 20%, the THV
nscatheter aortic valve replacement; other abbreviations as in Figures 1 and 2.
defined as oversized when the external valve area is greater than
nd by 24% from a 26- to 29-mm THV. Abbreviations as in Figures 1 and 2.rsizin
st-TA
.5 mm
.3%). (
 traTHV is
THV a
11
1
1
1
1
1
1
1
1
2
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CT Predicts TAVR Paravalvular Regurgitation April 3, 2012:1287–94Conclusions
MDCT annular measurements are reproducible and strongly
predictive of significant PAR. THVs that are oversized relative
to the MDCT mean annular diameter by at least 1 mm and
annular area by at least 10% have a significantly reduced risk of
moderate or severe PAR. Modest THV oversizing relative to
MDCT annular area was not associated with THV eccentric-
ity or underexpansion. Future studies assessing whether inten-
tional oversizing by MDCT criteria reduces PAR without an
increased risk of complications is warranted.
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